Zenas BioPharma, Inc. (ZBIO)
20.97
-0.08
(-0.38%)
USD |
NASDAQ |
Apr 16, 12:49
Zenas BioPharma Price to Book Value : 5.401 for April 16, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ADMA Biologics, Inc. | 5.291 |
| AnaptysBio, Inc. | 52.04 |
| Gilead Sciences, Inc. | 7.583 |
| Nkarta, Inc. | 0.6232 |
| Cullinan Therapeutics, Inc. | 2.178 |
Price to Book Value Related Metrics
| PS Ratio | 90.34 |
| PEG Ratio | -0.0213 |
| Price | 20.97 |
| Earnings Yield | -40.27% |
| Market Cap | 1.308B |
| PEGY Ratio | -0.0213 |